SPERO THERAPEUTICS INC (SPRO) Stock Analyst Ratings
USA - NASDAQ:SPRO - US84833T1034 - Common Stock
2.47 USD
+0.04 (+1.65%)
ChartMill assigns a Buy % Consensus number of 46% to SPRO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 106.48% above the current price.
SPRO was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about SPRO.
In the previous month the buy percentage consensus was at a similar level.
SPRO was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-20 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2024-12-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-18 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-11-15 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-11-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-06 | TD Cowen | Upgrade | Hold -> Buy |
| 2024-08-06 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-08-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-04 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-09-26 | HC Wainwright & Co. | Maintains | Buy |
| 2022-09-23 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2022-08-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-23 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-20 | Berenberg | Downgrade | Buy -> Hold |
| 2022-05-17 | Cantor Fitzgerald | Maintains | Overweight |
| 2022-05-04 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2022-05-04 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2022-04-18 | HC Wainwright & Co. | Maintains | Buy |
| 2021-10-01 | Oppenheimer | Downgrade | Outperform -> Perform |
SPERO THERAPEUTICS INC / SPRO FAQ
What is the average price target for SPERO THERAPEUTICS INC (SPRO) stock?
7 analysts have analysed SPRO and the average price target is 5.1 USD. This implies a price increase of 106.48% is expected in the next year compared to the current price of 2.47.
What is the consensus rating for SPRO stock?
The consensus rating for SPERO THERAPEUTICS INC (SPRO) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.